World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone

By C. Fletcher, K. Unni, F. Mertens. 2002

4,545 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/b62adb76c5a5a58d3acfd8ee63e198e41139af6f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. B. N. Binh
2. C. Fletcher
3. S. Singer
4. J. Toro
5. L. Guillou
6. X. Sastre‐Garau
7. C. Antonescu
8. L. Travis

Citations in the corpus

• The epidemiology of osteosarcoma. (2009, background): “Cancer registry data with histologic stratification indicate that osteosarcoma is the most common primary malignant tumor of the bone among people of all ages, accounting for approximately 35% of cases, followed by chondrosarcoma (25%) and Ewing sarcoma (16%).(12) Among childhood cancers, osteosarco”
• Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma (2003, methodology): “Histologic subtype and grade was assigned by following the published criteria of the World Health Organization Classification of Tumors of Soft Tissue and Bone.12 Histologic subtype was classified as well-differentiated, dedifferentiated, myxoid/round cell, or pleomorphic.”
• Perivascular Epithelioid Cell Neoplasms of Soft Tissue and Gynecologic Origin: A Clinicopathologic Study of 26 Cases and Review of the Literature (2005, background): “’’(6) The PEComa family of tumors has subsequently grown to include AML, CCST, lymphangioleiomyomatosis (LAM), and a number of unusual visceral, intraabdominal, soft tissue and bone tumors, which have been described under a variety of names, including ‘‘clear cell myomelanocytic tumor of the falcifo”
• The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification (2014, background): “These lesions have been shown to harbour the same chromosome translocation t(1;10)(p22;q24) as identified in myxoinflammatory fibroblastic sarcoma (also known as atypical myxoinflammatory fibroblastic tumour) (see above),(28,29) and tumours showing hybrid morphology have been recognized.”
• Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases (2006, methodology): “are now recognized as a variant of angiosarcoma.(3) We also”
• MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes: A Comparative Analysis of 559 Soft Tissue Neoplasms With Genetic Data (2005, methodology): “Tumors were classified according to the latest WHO classification for bone and soft tissue tumors.(13) Of the 559 soft tissue tumors selected, 244 cases had been collegially reviewed by the pathologists of the French Sarcoma Group.”